# Bionano Genomics, Inc.: Form DEF 14A, filed Aug 21, 2024

- Company: [Bionano Genomics, Inc.](/companies/bngo.md) (CIK 1411690)
- Form: DEF 14A
- Filed: 2024-08-21
- Accepted by EDGAR: Aug 21, 2024, 16:59 ET
- Period: 2024-10-02
- Accession: 0001140361-24-038087
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1411690/000114036124038087/ny20032632x2_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1411690/000114036124038087/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1411690/000114036124038087/ny20032632x2_def14a.htm

Filed Aug 21, 2024.
Source: SEC EDGAR, the filing index for accession 0001140361-24-038087. Last ingested by Listed: Nov 6, 2026, 10:56 ET. No prices; not investment advice.
